#Steeven.™ Posted February 5, 2021 Posted February 5, 2021 The COVID-19 vaccine developed by the University of Oxford and the pharmaceutical company AstraZeneca is equally effective against the new British variant of the coronavirus, according to new scientific evidence released this Friday. Scientists from the aforementioned British academic center who created the preparation point to a similar effect when it comes to fighting against the variant as when they do against the original strain of COVID-19, used in clinical trials. The scientific community was concerned that the vaccines currently administered in this country to immunize the po[CENSORED]tion could no longer be effective against the new British variant of the virus. The study, which has not yet been officially published, also describes the analysis that suggests that vaccinating with the Oxford / AstraZeneca preparation results in a reduction in the duration of viral load, which could translate into a decrease in transmission. of the illness. Andrew Pollard, professor of pediatric infection and immunity and chief investigator of the Oxford vaccine trials, said today that data from the trials in this country "indicates that the vaccine not only protects against the original virus of the pandemic but also against the new variant, B117, which has caused the disease to rebound since late 2020 across the UK. " Boris Johnson's Executive has set the goal of having vaccinated 15 million citizens before the next day 15 and announced this Friday that all adults over 50 years of age should have received the vaccine by next May. So far, more than 10.4 million people in this country have already received their first dose (of a total of two) of the preparation to combat the coronavirus, according to official data. 1
Recommended Posts